Literature DB >> 8428780

Regional angiotensin II production in essential hypertension and renal artery stenosis.

P J Admiraal1, A H Danser, M S Jong, H Pieterman, F H Derkx, M A Schalekamp.   

Abstract

To study regional metabolism and production of angiotensin II, we measured steady-state plasma levels of 125I-angiotensin I and II and endogenous angiotensin I and II in the aorta and the antecubital, femoral, renal, and hepatic veins during systemic infusion of 125I-angiotensin I or II. Extraction of arterially delivered angiotensin II ranged from 30-50% in the limbs to 80-100% in the renal and hepatomesenteric vascular beds both in essential hypertension (n = 13) and in unilateral renal artery stenosis (n = 7). Across the limbs, 20-30% of arterially delivered angiotensin I was converted to angiotensin II in both groups, and there was no arteriovenous gradient in endogenous angiotensin II. No conversion of arterially delivered angiotensin I was detected across the renal and hepatomesenteric beds, and there was net extraction of angiotensin II from the systemic circulation by these beds. Although regional production of angiotensin I at tissue sites made a significant contribution to its level in the veins, little of this locally produced angiotensin I reached the regional veins in the form of angiotensin II, even in the kidney with artery stenosis, where the venous levels of locally produced angiotensin I were particularly high. These results provide no evidence for a source of circulating angiotensin II other than blood-borne angiotensin I and illustrate the high degree of compartmentalization of angiotensin I and II production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428780     DOI: 10.1161/01.hyp.21.2.173

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Vasoconstriction is determined by interstitial rather than circulating angiotensin II.

Authors:  Martin P Schuijt; René de Vries; Pramod R Saxena; Maarten A D H Schalekamp; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

Review 2.  Local renin-angiotensin systems.

Authors:  A H Danser
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 3.  Should we aim at tissue renin-angiotensin systems?

Authors:  J F Smits; R C Passier; M J Daemen
Journal:  Pharm World Sci       Date:  1998-06

4.  Future direction of renal positron emission tomography.

Authors:  Zsolt Szabo; Jinsong Xia; William B Mathews; Phillip R Brown
Journal:  Semin Nucl Med       Date:  2006-01       Impact factor: 4.446

Review 5.  Is there an internal cardiac renin-angiotensin system?

Authors:  A H Danser; M A Schalekamp
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.

Authors:  L S Zisman; W T Abraham; G E Meixell; B N Vamvakias; R A Quaife; B D Lowes; R L Roden; S J Peacock; B M Groves; M V Raynolds
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Urinary excretion of renin and angiotensinogen in hypertensive children and adolescents.

Authors:  Magdalena Zając; Agnieszka Rybi-Szumińska; Justyna Storonowicz; Piotr Protas; Anna Wasilewska
Journal:  Arch Med Sci       Date:  2019-10-07       Impact factor: 3.318

8.  Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor.

Authors:  Daan H H M Viering; Anneke P Bech; Jeroen H F de Baaij; Eric J Steenbergen; A H Jan Danser; Jack F M Wetzels; René J M Bindels; Jaap Deinum
Journal:  Pediatr Nephrol       Date:  2021-03-25       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.